Zahra Maryam
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Zahra Maryam has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Abdüllatif Karakaya
Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Zonguldak Bülent Ecevit University, 67600 Zonguldak, Turkey
2 shared publications - Tugba Ercetin
Doğu Akdeniz Üniversitesi
2 shared publications - Ulviye Acar Çevik
Anadolu University
2 shared publications - Betül Kaya Çavuşoğlu
Bilecik Seyh Edebali University
1 shared publication - Emine Rana Bağci
Afyonkarahisar Health Sciences University
1 shared publication - Nour El-Huda Daoud
Department of Pharmaceutical Chemistry, Faculty of Pharmacy Anadolu University Eskişehir Turkey
1 shared publication
Latest Publications
- 30 October 2025
- Published by FABAD Farmasotik Bilimler Ankara Dernegi in Fabad Journal of Pharmaceutical Sciences
- Vol. 50 (3) , 531-546
Synthesis of Novel Benzofuran-Based Thiazole Hybrids and Investigation of Their Antioxidant and Anticholinesterase Activities
In this study, a novel series of benzofuran derivatives (2a-2k) were synthesized and the structures of the obtained compounds were elucidated by 1H NMR, 13C NMR and HRMS spectra. The compounds were investigated for their anticholinesterase and antioxidant potentials. The ferrous ion chelating activity of the compound 2g at 50 µM concentration was 68.25%, surpassing those of rutin and BHT (13.21% and 2.57%, respectively). Besides, according to DPPH radical scavenging activity assay, compound 2g exhibited the most potent antioxidant activity with an IC50 value of 30.14 ± 0.005 µM, when compared to standard gallic acid (IC50= 29.48 ± 0.014 µM). Furthermore, compounds 2d (10.33%) and 2i (20.17%), showed the highest inhibitory activity against AChE and BChE, respectively. Compound 2i exhibits important interactions with the active site of BChE, according to the in silico molecular docking study. Also, the in silico ADMET study revealed the desirable pharmacokinetic properties of compound 2i. Therefore, compounds 2g and 2i could be deemed as promising candidates for the designing dual functional antioxidant and butyrylcholinesterase inhibitors in the management of Alzheimer’s disease.
- 30 October 2025
- Published by FABAD Farmasotik Bilimler Ankara Dernegi in Fabad Journal of Pharmaceutical Sciences
- Vol. 50 (3) , 531-546
Synthesis of Novel Benzofuran-Based Thiazole Hybrids and Investigation of Their Antioxidant and Anticholinesterase Activities
In this study, a novel series of benzofuran derivatives (2a-2k) were synthesized and the structures of the obtained compounds were elucidated by 1H NMR, 13C NMR and HRMS spectra. The compounds were investigated for their anticholinesterase and antioxidant potentials. The ferrous ion chelating activity of the compound 2g at 50 µM concentration was 68.25%, surpassing those of rutin and BHT (13.21% and 2.57%, respectively). Besides, according to DPPH radical scavenging activity assay, compound 2g exhibited the most potent antioxidant activity with an IC50 value of 30.14 ± 0.005 µM, when compared to standard gallic acid (IC50= 29.48 ± 0.014 µM). Furthermore, compounds 2d (10.33%) and 2i (20.17%), showed the highest inhibitory activity against AChE and BChE, respectively. Compound 2i exhibits important interactions with the active site of BChE, according to the in silico molecular docking study. Also, the in silico ADMET study revealed the desirable pharmacokinetic properties of compound 2i. Therefore, compounds 2g and 2i could be deemed as promising candidates for the designing dual functional antioxidant and butyrylcholinesterase inhibitors in the management of Alzheimer’s disease.
- Open Access
- 29 December 2023
- Published by Anadolu University Faculty of Pharmacy in European Journal of Life Sciences
- Vol. 2 (3) , 118-124
Synthesis of thiazole derivatives as cholinesterase inhibitors with antioxidant activity
In the present research, we synthesized two unique series of thiazole compounds having 5-bromothiophene and 3-methylthiophene (2a-2f) in their structure. After that, spectroscopic methods were used to analyze the chemical compositions of the newly synthesized molecules. Then in vitro evaluation was done to determine acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) activity of the synthesized compounds using galantamine as reference standard. The compounds’ antioxidant properties were assessed using DPPH radical scavenging and ferrous ion-chelating techniques. The results of the study showed weak anticholinesterase activity against AChE and BuChE enzymes for all the final compounds. The synthesized analogs also showed significant DPPH radical scavenging activities with IC50 values in the range of 29.16 ± 0.009 to 33.09 ± 0.004 µM (for DDPH) incomparison to standard gallic acid with IC50 = 31.13 ± 0.008 µM (for DDPH). Especially, compound 2c showed the best antioxidant activity with IC50 value of 29.16 ± 0.009 µM.
- 29 December 2023
- Published by Anadolu University Faculty of Pharmacy in European Journal of Life Sciences
- Vol. 2 (3) , 118-124
Open AccessSynthesis of thiazole derivatives as cholinesterase inhibitors with antioxidant activity
In the present research, we synthesized two unique series of thiazole compounds having 5-bromothiophene and 3-methylthiophene (2a-2f) in their structure. After that, spectroscopic methods were used to analyze the chemical compositions of the newly synthesized molecules. Then in vitro evaluation was done to determine acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) activity of the synthesized compounds using galantamine as reference standard. The compounds’ antioxidant properties were assessed using DPPH radical scavenging and ferrous ion-chelating techniques. The results of the study showed weak anticholinesterase activity against AChE and BuChE enzymes for all the final compounds. The synthesized analogs also showed significant DPPH radical scavenging activities with IC50 values in the range of 29.16 ± 0.009 to 33.09 ± 0.004 µM (for DDPH) incomparison to standard gallic acid with IC50 = 31.13 ± 0.008 µM (for DDPH). Especially, compound 2c showed the best antioxidant activity with IC50 value of 29.16 ± 0.009 µM.